AstraZeneca – AstraZeneca PLC ADR falls Thursday, underperforms market
The AstraZeneca PLC ADR
(AZN),
slipped 0.12% to $52.04 Thursday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index
COMP,
rising 0.50% to 13,337.16 and the Dow Jones Industrial Average
DJIA,
rising 0.99% to 30,603.36. This was the ADR’s second consecutive day of losses. AstraZeneca PLC ADR closed $12.90 below its 52-week high ($64.94), which the company reached on July 20th.
The ADR demonstrated a mixed performance when compared to some of its competitors Thursday, as AbbVie Inc.
ABBV,
rose 1.38% to $104.21, Amgen Inc.
AMGN,
fell 1.32% to $247.75, and Gilead Sciences Inc.
GILD,
fell 1.22% to $64.68. Trading volume (8.4 M) remained 3.8 million below its 50-day average volume of 12.2 M.
Editor’s Note: This story was auto-generated by Automated Insights using data from Dow Jones and FactSet. See our market data terms of use.
